Mitsubishi Tanabe Pharma America Announces EXSERVAN(TM) (riluzole) is Now Available in the U.S. for the Treatment of ALS
New Innovative Orally Dissolving Film Designed to Help Meet the Needs of ALS Patients Who Have Difficulty Swallowing Some Medications
JERSEY CITY, N.J., June 30, 2021 -- (Healthcare Sales & Marketing Network) -- Mitsubishi Tanabe Pharma America, Inc. (... Biopharmaceuticals, Neurology, Product Launch Mitsubishi Tanabe Pharma, EXSERVAN, riluzole, amyotrophic lateral sclerosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 30, 2021 Category: Pharmaceuticals Source Type: news
Cedars-Sinai awarded $11.99 million for ALS clinical trial
(Cedars-Sinai Medical Center) Cedars-Sinai has been awarded $11.99 million by California's stem cell agency to launch a clinical trial testing a potential gene and stem cell therapy for amyotrophic lateral sclerosis (ALS). (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - June 23, 2021 Category: Biology Source Type: news
Study finds abnormal response to cellular stress is associated with Huntington's disease
(University of California - Irvine) A new University of California, Irvine-led study finds that the persistence of a marker of chronic cellular stress, previously associated with neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), also takes place in the brains of Huntington's disease (HD) patients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 23, 2021 Category: International Medicine & Public Health Source Type: news
New Genetic Insights Into Cause of ALS
MONDAY, June 21, 2021 -- Researchers say they ' ve identified a new gene associated with an increased risk of amyotrophic lateral sclerosis (ALS) -- and that their discovery could lead to improved treatments for the deadly disease.
ALS -- also called... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 21, 2021 Category: General Medicine Source Type: news
New Gene Variants Identified That May Raise Risk for ALS
THURSDAY, June 17, 2021 -- Variants in TP73 are associated with risk for amyotrophic lateral sclerosis (ALS), according to a study published online June 16 in Neurology.
Kristi L. Russell, from the University of Utah School of Medicine in Salt Lake... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 17, 2021 Category: Pharmaceuticals Source Type: news
Cell Reports publishes data supporting the importance of ion channel, Kv7.2/7.3 as a target in ALS
(LaVoieHealthScience) QurAlis Corporation today announced the publication of an article in Cell Reports titled Human Amyotrophic Lateral Sclerosis Excitability Phenotype Screen: Target Discovery and Validation by QurAlis founders Kasper Roet, Ph.D., Clifford Woolf, M.D., Ph.D., and Kevin Eggan, Ph.D., who pioneered a high-content, live-cell imaging screen using ALS patient-derived motor neurons in combination with a compound library generated by Pfizer to identify drug targets to treat hyperexcitability induced neurodegeneration in ALS patients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 8, 2021 Category: International Medicine & Public Health Source Type: news
5 Minutes With ... Steve Kowalski, ALS Foundation board secretary
Steve Kowalski was diagnosed four years ago with amyotrophic lateral sclerosis (ALS). He is now board secretary of the Mass. chapter of The ALS Association, helping raise awareness, and funding, for research and resources for ALS patients and their families. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - June 3, 2021 Category: Health Management Authors: Jim Morrison Source Type: news
Scientists Discover Rare Form of ALS That Can Strike Kids
WEDNESDAY, June 2, 2021 -- A new form of amyotrophic lateral sclerosis (ALS) that affects children has been discovered by an international team of researchers.
They used advanced genetic techniques to identify 11 such cases in children who had... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 2, 2021 Category: General Medicine Source Type: news
Amyotrophic lateral sclerosis presents a & quot;considerable & quot; economic burden
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - June 1, 2021 Category: Drugs & Pharmacology Source Type: news
Scientists discover a new genetic form of ALS in children
(NIH/National Institute of Neurological Disorders and Stroke) In a study of 11 medical-mystery patients, an international team of researchers led by scientists at the National Institutes of Health and the Uniformed Services University (USU) discovered a new and unique form of amyotrophic lateral sclerosis (ALS). Unlike most cases of ALS, the disease began attacking these patients during childhood, worsened more slowly than usual, and was linked to a gene, called SPTLC1, that is part of the body's fat production system. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 31, 2021 Category: International Medicine & Public Health Source Type: news
Science Saturday: How regenerative medicine is advancing ALS research
May is?ALS Awareness Month, a time to reflect on the role of regenerative medicine research in advancing understanding and treatment of amyotrophic lateral sclerosis?(ALS) or Lou Gehrig's disease. This neurodegenerative disorder causes nerve cells in the brain and spinal cord to die, blocking signals to the muscles. That results in paralysis that robs a person [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - May 29, 2021 Category: Databases & Libraries Source Type: news
Consumer Health: What do you know about Lou Gehrig's disease?
May is ALS Awareness Month, which makes this a good time to learn more about Lou Gehrig's disease, which is also known as amyotrophic lateral sclerosis, or ALS. Amyotrophic lateral sclerosis is a progressive nervous system disease that affects nerve cells in the brain and spinal cord, causing loss of muscle control. More than 5,000 people [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - May 23, 2021 Category: Databases & Libraries Source Type: news
CNIO researchers discover the cause of neuronal death in a large proportion of familial ALS patients
(Centro Nacional de Investigaciones Oncol รณ gicas (CNIO)) The researchers attribute the loss of motor neurons in patients with Amyotrophic Lateral Sclerosis (ALS) to a new mechanism that blocks any cellular reaction that involves nucleic acids (DNA or RNA)Many cellular processes involving nucleic acids fail in the motor neurons of ALS patients; the mechanism discovered by the CNIO group finally explains these widespread problems that have been reported for yearsThe paper is published this week in 'The EMBO Journal' (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 12, 2021 Category: International Medicine & Public Health Source Type: news
Discovering the Secrets of Motor Neurons with Single Cell Sequencing
Researchers identify new motor neuron subgroups and gain insights into amyotrophic lateral sclerosis (ALS). (Source: The Scientist)
Source: The Scientist - May 5, 2021 Category: Science Tags: Podcasts Source Type: news
After pressure, Biogen to expand compassionate use for ALS drug
Following pressure by advocates for patients with amyotrophic lateral sclerosis, or ALS, Biogen has expanded its early access program to an experimental ALS drug called tofersen. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - April 27, 2021 Category: Health Management Authors: Rowan Walrath Source Type: news
